PFM Health Sciences’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

PFM Health Sciences’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-154,599	Closed	-$15.8M	–	109
2019 Q2	$15.8M	Sell	154,599 -61,222	-28%	-$6.61M	0.3%	70
2019 Q1	$24.6M	Sell	215,821 -1,967,572	-90%	-$145M	0.54%	61
2018 Q4	$85.5M	Buy	2,183,393 +1,323,913	+154%	+$57.4M	2.27%	9
2018 Q3	$46.9M	Sell	859,480 -17,299	-2%	-$1.18M	0.69%	54
2018 Q2	$72.6M	Buy	876,779 +239,143	+38%	+$18.5M	1.14%	31
2018 Q1	$42.5M	Buy	+637,636	New	+$36.8M	0.86%	45
2015 Q3	–	Sell	-77,141	Closed	-$4.65M	–	107
2015 Q2	$4.65M	Buy	+77,141	New	+$5.1M	0.12%	74

Other funds holding ONCE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

PFM Health Sciences's ONCE Position: Q3 2019 in Review

PFM Health Sciences sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2019, closing a stake of 154,599 shares — an estimated $15.8M sold.

PFM Health Sciences first reported a position in ONCE in Q2 2015 and held it in 7 quarters. The position peaked at $85.5M in Q4 2018. 184 funds tracked by Wall St. Rank hold ONCE as of Q3 2019.

PFM Health Sciences reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
PFM Health Sciences sold 154,599 Spark Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $15.8M.
PFM Health Sciences first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2015 and held it in 7 quarters.
PFM Health Sciences's Spark Therapeutics, Inc. Common Stock position peaked at $85.5M in Q4 2018.
184 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2019.

Based on PFM Health Sciences's 13F filing for Q3 2019, filed 14 Nov 2019.